(Q48935560)

17 February 2018

title

Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology. (English)

1 reference

17 February 2018

pediatric infratentorial ependymoma

main subject

1 reference

7

Hyo Seop Ahn

1 reference

17 February 2018

Kyung Duk Park

6

object named as

Kyung Duk Park

1 reference

17 February 2018

author name string

Ji Hoon Phi

1

1 reference

17 February 2018

Kyu-Chang Wang

2

1 reference

17 February 2018

Sung-Hye Park

3

1 reference

17 February 2018

Il Han Kim

4

1 reference

17 February 2018

In-One Kim

5

1 reference

17 February 2018

Ji Yeoun Lee

8

1 reference

17 February 2018

Young-Je Son

9

1 reference

17 February 2018

Seung-Ki Kim

10

1 reference

17 February 2018

publication date

24 August 2011

1 reference

17 February 2018

Journal of Neuro-Oncology

published in

1 reference

17 February 2018

volume

106

1 reference

17 February 2018

issue

3

1 reference

17 February 2018

page(s)

619-626

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-011-0699-x

exact match

0 references

cites work

Survival following treatment for intracranial ependymoma: a review

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Childhood intracranial ependymoma: twenty-year experience from a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Both location and age predict survival in ependymoma: a SEER study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Intracranial ependymomas of childhood: long-term outcome and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Molecular staging of intracranial ependymoma in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Postoperative radiation therapy for grade II and III intracranial ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

21 January 2018

Ependymoma: an update

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Outcome predictors for intracranial ependymoma radiosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0699-X

Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons

21 January 2018

1 reference

12 December 2020

Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy.

1 reference

12 December 2020

The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors

1 reference

12 December 2020

Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?

1 reference

12 December 2020

Overexpression of cyclooxygenase-2 in childhood ependymomas: role of COX-2 inhibitor in growth and multi-drug resistance in vitro.

1 reference

12 December 2020

P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) localize in the microvessels forming the blood-tumor barrier in ependymomas.

1 reference

12 December 2020

10.1007/S11060-011-0699-X

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

21863401

1 reference

17 February 2018